NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Elizabeth Arden, Inc. (NASDAQ: RDEN) investors concerning the proposed acquisition of the company by Revlon, Inc.
The investigation concerns whether Elizabeth Arden’s board of directors failed to adequately shop the Company and obtain the best possible value for Elizabeth Arden stockholders before entering into a definitive merger agreement with Revlon. Under the terms of the agreement, Elizabeth Arden stockholders will receive $14.00 in cash for each share of Elizabeth Arden common stock held in a transaction valued at approximately $870 million.
If you purchased Elizabeth Arden securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters please contact J. Brandon Walker, Esq. by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information, please go to www.bespc.com.